Label: VASELINE- aging chest and neck rescue treatment cream cream
- NDC Code(s): 64942-1877-1, 64942-1877-2
- Packager: CONOPCO Inc. d/b/a Unilever
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 7, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- VASELINE AGING CHEST & NECK RESCUE TREATMENT CREAM SUNSCREEN SPF 30 - (sunscreen, avobenzone, homosalate, octisalate, octocrylene) cream
- Drug Facts
- Purpose
- Uses
- Warnings
- KEEP OUT OF REACH OF CHILDREN
-
Directions
Apply liberally 15 minutes before sun exposure
Children under 6 months of age: Ask a doctor.
Reapply at least every 2 hours
Use a water resistant sunscreen if swimming or sweating
Sun Protection Measures Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this rish, regularly use a sunscree with a Broad Spectum SPF value of 15 or higher and other sun protection measures including limit time in the sun,- especially from 10a.m. - 2p.m.
- wear long-sleeved shirts, pants, hats and sunglasses
-
Inactive ingredients
Water (Eau), Glycerin, C12-15 Alkyl Benzoate, Stearic Acid, Dimethicone, Laureth-23, Glycol Stearate, Cetyl Alcohol, Glyceryl Stearate, Ammonium Acryloyldimethyltaurate/VP Copolymer, Dimethicone Crosspolymer, Petrolatum, Fragrance (Parfum), Sodium Benzoate, Xanthan Gum, Citric Acid, Potassium Sorbate, Disodium EDTA, Niacinamide, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Stearamide AMP, Sodium Ascorbyl Phosphate, Tocopheryl Acetate, Hydroxystearic Acid, Sodium Hyaluronate, Benzyl Alcohol.
- Questions or Comments?
- Packaging
-
INGREDIENTS AND APPEARANCE
VASELINE
aging chest and neck rescue treatment cream creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:64942-1877 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 7.5 g in 100 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 5 g in 100 mL AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 2 g in 100 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 3 g in 100 mL Inactive Ingredients Ingredient Name Strength GLYCOL STEARATE (UNII: 0324G66D0E) WATER (UNII: 059QF0KO0R) NIACINAMIDE (UNII: 25X51I8RD4) CETYL ALCOHOL (UNII: 936JST6JCN) XANTHAN GUM (UNII: TTV12P4NEE) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER (UNII: W59H9296ZG) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) DIMETHICONE (UNII: 92RU3N3Y1O) SODIUM BENZOATE (UNII: OJ245FE5EU) GLYCERIN (UNII: PDC6A3C0OX) 12-HYDROXYSTEARIC ACID (UNII: 933ANU3H2S) EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM) STEARAMIDE AMP (UNII: U3K8640346) SODIUM ASCORBYL PHOSPHATE (UNII: 836SJG51DR) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) STEARIC ACID (UNII: 4ELV7Z65AP) PETROLATUM (UNII: 4T6H12BN9U) DIMETHICONE CROSSPOLYMER (450000 MPA.S AT 12% IN CYCLOPENTASILOXANE) (UNII: UF7620L1W6) LAURETH-23 (UNII: N72LMW566G) PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS) HYALURONATE SODIUM (UNII: YSE9PPT4TH) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) BENZYL ALCOHOL (UNII: LKG8494WBH) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:64942-1877-2 1 in 1 CARTON 02/12/2021 1 NDC:64942-1877-1 60 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part352 02/12/2021 Labeler - CONOPCO Inc. d/b/a Unilever (001375088)
